Literature DB >> 7779853

Heat shock protein-induced T-lymphocyte propagation from endomyocardial biopsies in heart transplantation.

R Moliterno1, M Woan, C Bentlejewski, J Qian, A Zeevi, S Pham, B P Griffith, R J Duquesnoy.   

Abstract

BACKGROUND: Recent studies have shown that heat shock proteins can be recognized by T cells during various immunologically mediated inflammatory processes. Injurious stimuli to cells induce an increased production of heat shock proteins which could lead to their cell surface expression and subsequent recognition by the immune system. We have postulated that allograft infiltrating cells may recognize heat shock proteins, especially during rejection.
METHODS: This hypothesis was tested by incubating heart transplant biopsy specimens from 89 heart transplant recipients with soluble Mycobacterium tuberculosis extracts, a source of heat shock proteins or recombinant mycobacterial heat shock protein 65. T cell phenotypes were determined by flow cytometry.
RESULTS: Mycobacterium tuberculosis extract can induce lymphocyte propagation from heart transplant biopsy specimens especially during rejection. A highly significant correlation was seen between Mycobacterium tuberculosis extract and interleukin-2-induced lymphocyte growth and an accelerated growth was seen for cultures incubated with Mycobacterium tuberculosis extract + interleukin-2. A second series of experiments has also shown the propagation of lymphocytes induced by recombinant mycobacterial heat shock protein-65. T-cell phenotype analysis of biopsy propagated lymphocytes has shown higher frequencies of CD8 cells in Mycobacterium tuberculosis extract and heat shock protein-65 propagated lymphocytes from early posttransplantation biopsy specimens, whereas, later on, most cultures showed a predominance of CD4 cells. T-cell receptor gamma delta cells were more frequently found in biopsy-derived lymphocyte cultures from long-term survivors, especially after propagation with Mycobacterium tuberculosis extract and heat shock protein-65. These gamma delta cells expressed primarily the delta 1 rather than the gamma 9 phenotype.
CONCLUSIONS: These observations provide first evidence for the presence of heat shock protein-reactive lymphocytes in cellular infiltrates of transplants undergoing rejection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779853

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

1.  Heat-shock proteins: inflammatory versus regulatory attributes.

Authors:  Verônica Coelho; Femke Broere; Robert J Binder; Yehuda Shoenfeld; Kamal D Moudgil
Journal:  Cell Stress Chaperones       Date:  2008-02-28       Impact factor: 3.667

Review 2.  Danger signals in regulating the immune response to solid organ transplantation.

Authors:  Jamie L Todd; Scott M Palmer
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

3.  Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses.

Authors:  C Caldas; E Luna; M Spadafora-Ferreira; G Porto; L K Iwai; S E Oshiro; S M Monteiro; J A Fonseca; F Lemos; J Hammer; P L Ho; J Kalil; V Coelho
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

4.  Correlation between heat shock proteins, adiponectin, and T lymphocyte cytokine expression in type 2 diabetics.

Authors:  Fadia F Mahmoud; David Haines; Ali A Dashti; Sherief El-Shazly; Fawzia Al-Najjar
Journal:  Cell Stress Chaperones       Date:  2018-05-11       Impact factor: 3.667

5.  Autoimmune Reactivity in Graft Injury: Player or Bystander?

Authors:  Vrushali V Agashe; William J Burlingham
Journal:  Curr Transplant Rep       Date:  2015-07-07

6.  Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.

Authors:  M J Maeurer; D Martin; W Walter; K Liu; L Zitvogel; K Halusczcak; H Rabinowich; R Duquesnoy; W Storkus; M T Lotze
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.